# Quercetin In The Treatment Of SARS-COV 2

> **NCT04853199** · EARLY_PHASE1 · COMPLETED · sponsor: **Hôpital Universitaire Sahloul** · enrollment: 200 (actual)

## Conditions studied

- SARS (Severe Acute Respiratory Syndrome)

## Interventions

- **DRUG:** Quercetin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04853199
- **Lead sponsor:** Hôpital Universitaire Sahloul
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04853199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04853199, "Quercetin In The Treatment Of SARS-COV 2". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04853199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*